Current Understanding and Future Perspectives on Hyperprogressive Disease Highlight the Tumor Microenvironment-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Current Understanding and Future Perspectives on Hyperprogressive Disease Highlight the Tumor Microenvironment

Published:2022-04-19 Issue:9 Volume:62 Page:1059-1078
ISSN:0091-2700
Container-title:The Journal of Clinical Pharmacology
language:en
Short-container-title:The Journal of Clinical Pharma

Author:

Li Meiqi¹²³,Zhong Xianmei¹²³,Du Fukuan¹²³,Wu Xu¹²³,Li Mingxing¹²³,Chen Yu¹²³,Zhao Yueshui¹²³,Shen Jing¹²³,Yang Zhongming⁴,Xiao Zhangang¹²³

Affiliation:

1. Laboratory of Molecular Pharmacology Department of Pharmacology School of Pharmacy Southwest Medical University Luzhou Sichuan China

2. Cell Therapy & Cell Drugs of Luzhou Key Laboratory Luzhou Sichuan China

3. South Sichuan Institute of Translational Medicine Luzhou Sichuan China

4. Department of Oncology and Hematology The Affiliated Traditional Chinese Medicine Hospital of Southwest Medical University Luzhou Sichuan China

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jcph.2048

Reference143 articles.

1. Nobel committee honors tumor immunologists

2. Immune checkpoint inhibitors: recent progress and potential biomarkers

3. Immune Checkpoint Inhibitors

4. PD-L1 and immune infiltrates are differentially expressed in distinct subgroups of gastric cancer

5. The promising immune checkpoint LAG-3: from tumor microenvironment to cancer immunotherapy

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP